What Happened?
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 3.6% in the afternoon session after the company announced the launch of rapid cell banking programs designed to accelerate release timelines.
According to a company press release, the newly launched programs offer a 40% reduction in cell bank production time compared to the 20-week industry standard. Under the comprehensive solution, rapid cell bank and release packages are paired with Next-Generation Sequencing characterization. Charles River Laboratories stated that this solution is designed to improve product quality, safety, and regulatory readiness while reducing overall development timelines.
The shares closed the day at $281.70, up 3% from the previous close.
Is now the time to buy Charles River Laboratories? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Charles River Laboratories’s shares are quite volatile and have had 19 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 10 months ago when the stock gained 6.1% on the news that the company provided an encouraging business update at an investor conference, highlighting positive demand trends. During a presentation at the Evercore Healthcare Conference, management reported that demand in its Discovery and Safety Assessment (DSA) segment showed improvement. Specifically, the company's net book-to-bill ratio, a key indicator comparing new orders to completed work, had risen each month since the start of the third fiscal quarter. While Charles River noted that holiday seasonality could affect short-term bookings, the company expressed optimism about the positive momentum and upward trends observed since the middle of 2025.
Charles River Laboratories is up 38.1% since the beginning of the year, and at $279.64 per share, it is trading close to its 52-week high of $298.58 from August 2026. Despite the year-to-date gain, investors who bought $1,000 worth of Charles River Laboratories’s shares 5 years ago would now be looking at only $634.89.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.